{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:40:01Z","timestamp":1790674801378,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1124\/jpet.120.000359","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T20:45:36Z","timestamp":1607633136000},"page":"348-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution"],"prefix":"10.1016","volume":"376","author":[{"given":"Mathieu","family":"Panel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhakim","family":"Ahmed-Belkacem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Guichou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Pawlotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Ghaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000359_bib1","doi-asserted-by":"crossref","first-page":"12777","DOI":"10.1038\/ncomms12777","article-title":"Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities","volume":"7","author":"Ahmed-Belkacem","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.120.000359_bib2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","article-title":"Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death","volume":"434","author":"Baines","year":"2005","journal-title":"Nature"},{"key":"10.1124\/jpet.120.000359_bib3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1742-4658.2006.05213.x","article-title":"The mitochondrial permeability transition from in vitro artifact to disease target [published correction appears in FEBS J (2006) 273:2578]","volume":"273","author":"Bernardi","year":"2006","journal-title":"FEBS J"},{"key":"10.1124\/jpet.120.000359_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacc.2015.11.024","article-title":"Cyclosporine A prior to primary PCI in STEMI patients: the Coup de Gr\u00e2ce to post-conditioning?","volume":"67","author":"Chen-Scarabelli","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.120.000359_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","article-title":"Cyclosporine before PCI in patients with acute myocardial infarction","volume":"373","author":"Cung","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000359_bib6","doi-asserted-by":"crossref","first-page":"e1000439","DOI":"10.1371\/journal.pbio.1000439","article-title":"Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases","volume":"8","author":"Davis","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1124\/jpet.120.000359_bib7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1089\/ars.2010.3375","article-title":"Mitochondrial injury and protection in ischemic pre- and postconditioning","volume":"14","author":"Di Lisa","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.120.000359_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/BJ20111301","article-title":"A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes","volume":"441","author":"Dube","year":"2012","journal-title":"Biochem J"},{"key":"10.1124\/jpet.120.000359_bib9","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1021\/acs.jmedchem.6b00411","article-title":"Peptidyl-proline isomerases (PPIases): targets for natural products and natural product-inspired compounds","volume":"59","author":"Dunyak","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000359_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.bjp.0701276","article-title":"Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation","volume":"121","author":"Elimadi","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000359_bib11","doi-asserted-by":"crossref","first-page":"25734","DOI":"10.1074\/jbc.273.40.25734","article-title":"A ubiquinone-binding site regulates the mitochondrial permeability transition pore","volume":"273","author":"Fontaine","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000359_bib12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.bbagen.2014.11.009","article-title":"Structural mechanisms of cyclophilin D-dependent control of the mitochondrial permeability transition pore","volume":"1850","author":"Guti\u00e9rrez-Aguilar","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.120.000359_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1042\/BST0380841","article-title":"A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection","volume":"38","author":"Halestrap","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/jpet.120.000359_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0008-6363(03)00533-9","article-title":"Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection","volume":"61","author":"Halestrap","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.120.000359_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yjmcc.2014.08.018","article-title":"The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia\/reperfusion injury","volume":"78","author":"Halestrap","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.120.000359_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","article-title":"Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery","volume":"111","author":"Hausenloy","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.120.000359_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cvr\/cvv225","article-title":"CIRCUS: a kiss of death for cardioprotection?","volume":"108","author":"Heusch","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.120.000359_bib18","doi-asserted-by":"crossref","first-page":"20467","DOI":"10.1038\/srep20467","article-title":"Nanoparticle-mediated targeting of cyclosporine A enhances cardioprotection against ischemia-reperfusion injury through inhibition of mitochondrial permeability transition pore opening","volume":"6","author":"Ikeda","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.120.000359_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/BJ20090332","article-title":"Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation","volume":"425","author":"Malouitre","year":"2009","journal-title":"Biochem J"},{"key":"10.1124\/jpet.120.000359_bib20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2009.10.052","article-title":"Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction","volume":"55","author":"Mewton","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.120.000359_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/fcp.12177","article-title":"Targeting myocardial reperfusion injuries with cyclosporine in the CIRCUS Trial - pharmacological reasons for failure","volume":"30","author":"Monassier","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/jpet.120.000359_bib22","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.2174\/092986709789712871","article-title":"Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection","volume":"16","author":"Morin","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.120.000359_bib23","doi-asserted-by":"crossref","first-page":"e00126-e18","DOI":"10.1128\/AAC.00126-18","article-title":"Characterization of the anti-hepatitis C virus activity of new nonpeptidic small-molecule cyclophilin inhibitors with the potential for broad anti-flaviviridae activity","volume":"62","author":"Nevers","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.120.000359_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.108.138008","article-title":"Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore","volume":"326","author":"Obame","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000359_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacc.2015.10.081","article-title":"Cyclosporine A in reperfused myocardial infarction: the multicenter, controlled, open-label CYCLE trial","volume":"67","author":"Ottani","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.120.000359_bib26","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1038\/s41598-017-04618-4","article-title":"Ca2+ ionophores are not suitable for inducing mPTP opening in murine isolated adult cardiac myocytes","volume":"7","author":"Panel","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.120.000359_bib27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2019.07.026","article-title":"Small-molecule inhibitors of cyclophilins block opening of the mitochondrial permeability transition pore and protect mice from hepatic ischemia\/reperfusion injury","volume":"157","author":"Panel","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.120.000359_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0006-3495(99)77239-5","article-title":"Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence","volume":"76","author":"Petronilli","year":"1999","journal-title":"Biophys J"},{"key":"10.1124\/jpet.120.000359_bib29","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1074\/jbc.M010604200","article-title":"The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ","volume":"276","author":"Petronilli","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000359_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJMoa071142","article-title":"Effect of cyclosporine on reperfusion injury in acute myocardial infarction","volume":"359","author":"Piot","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000359_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1124\/jpet.110.167486","article-title":"TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition","volume":"333","author":"Schaller","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000359_bib32","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.2174\/1381612822666160822150243","article-title":"Targeting mitochondria in cardiovascular diseases","volume":"22","author":"Silva","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.120.000359_bib33","doi-asserted-by":"crossref","first-page":"H928","DOI":"10.1152\/ajpheart.01135.2006","article-title":"Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress","volume":"293","author":"Townsend","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.120.000359_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jacbts.2016.06.012","article-title":"Mitochondrial membrane permeability inhibitors in acute myocardial infarction: still awaiting translation","volume":"1","author":"Trankle","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1124\/jpet.120.000359_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/gb-2005-6-7-226","article-title":"The cyclophilins","volume":"6","author":"Wang","year":"2005","journal-title":"Genome Biol"},{"key":"10.1124\/jpet.120.000359_bib36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N Engl J Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:53:56Z","timestamp":1739973236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524257657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0022356524257657"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000359","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}